Blog · Healthcare Services

Remote Patient Monitoring Services Are Consolidating Faster Than the Devices Are Changing

Three acquisitions in sixteen months show service providers racing to combine platforms and clinical services under one roof, even as Abbott proves there is still room for genuine device-level innovation.

Remote patient monitoring has moved from a pandemic-era convenience to a standard part of chronic disease management at many health systems. The more interesting story across 2025 and into 2026 is not that growth itself, but how quickly the service side of the market is consolidating, with multiple acquisitions announced just months apart. This article sets the market-sizing numbers in our companion report aside and looks at what has actually been acquired, funded, and cleared.

A Steady Drumbeat of Acquisitions

In March 2025, CoachCare acquired VitalTech, an enterprise virtual care software company, in its eighth acquisition since 2023. A year later, in March 2026, Health Recovery Solutions acquired Rimidi, a diabetes and cardiometabolic care platform, in what industry trackers counted as the fourth disclosed remote patient monitoring deal of that year alone. By June 2026, ChartSpan had acquired Validic, a connected-device data integration company, in a deal counted as the eighth remote patient monitoring acquisition and the 111th overall eHealth acquisition tracked so far that year.

The pattern across all three deals is similar: a service provider with its own monitoring platform acquires a company that adds either condition-specific clinical tools or broader device and data integration, rather than building that capability in-house.

Selected dated developments in remote patient monitoring services, March 2025 through June 2026. Signal-bar fill is illustrative only

Figure 1. Selected dated developments in remote patient monitoring services, March 2025 through June 2026. Signal-bar fill is illustrative only. Source: company and industry announcements cited throughout this article.

Smaller Players Are Combining Funding With Acquisitions

Not every deal in the category involves a large platform buying a smaller one outright. In November 2025, MiCare Path closed its fourth funding round and simultaneously announced the acquisition of Compwell, a Tennessee-based care management provider, in a single combined announcement. Pairing new capital directly with a tuck-in acquisition lets a smaller company expand its service offering and show growth to investors in one step, though it also means integration work begins at the same time the new funding arrives.

DateDevelopmentCategory
Mar 2025CoachCare acquires VitalTechAcquisition
Nov 2025MiCare Path funding round and Compwell acquisitionFunding / Acquisition
Mar 2026Health Recovery Solutions acquires RimidiAcquisition

Source: HIT Consultant (Mar 12, 2025); BriefGlance (Nov 25, 2025); Levin Associates (Mar 5, 2026).

Device Innovation Has Not Stopped

While service providers consolidate, device makers are still investing in incremental hardware improvements. In February 2026, Abbott received FDA clearance for a next-generation CardioMEMS HERO reader, about 60% lighter than earlier models and now built with both Wi-Fi and cellular connectivity so heart failure patients can transmit pulmonary artery pressure readings without extra equipment. Abbott pointed to a 57% reduction in hospitalizations associated with the earlier CardioMEMS system as the clinical basis for continuing to refine the device.

The contrast is worth noting: while much of the recent deal activity has focused on combining platforms and services, Abbott's clearance is a reminder that device-level improvements to an already-validated monitoring technology can still matter on their own, independent of which service provider ultimately deploys the device.

What to Watch

Three threads are worth tracking into the rest of 2026: whether the pace of remote patient monitoring acquisitions continues at the rate seen so far this year, whether newly combined platforms like ChartSpan and Validic can integrate quickly enough to retain the customers of both companies, and whether other device makers follow Abbott's lead in upgrading connectivity on already-approved monitoring hardware rather than pursuing entirely new device categories.

Companion report

Remote Patient Monitoring Services Market Report: Size, Share & Trends 2026–2035

This article provides editorial and R&D context only. For full market sizing, segmentation, regional share, competitive benchmarking and forecasts through 2035, see the companion Remote Patient Monitoring Services Market report.